KLRS Share Price Performance
US$4.75
-6.72 (-58.59%)
Price US$4.75
Share PriceUS$4.75
Kalaris Therapeutics, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
KLRS Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Kalaris Therapeutics, Inc. Key Details
About KLRS
- Founded
- 2019
- Employees
- 14
- CEO
- WebsiteView website
Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was incorporated in 2019 and is based in Palo Alto, California.
